BioXcel Therapeutics Inc (BTAI) earnings · rev $642.0K
These earnings events as JSON? API free 100/dayBioXcel Therapeutics Inc (BTAI) is a drug manufacturers - specialty & generic company listed on US.
This BTAI earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported BTAI revenue for 2025-12-31 was $642.0K. Net income was -$69.9M. Revenue was down 71.7% from 2024-12-31 to 2025-12-31. BTAI currently screens at market cap $36.1M.
When the next BTAI 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 71.7% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full BTAI research stays on the stock page; the tape stays on the quote page.
BTAI earnings FAQ
What are BTAI's latest revenue and net income?
Latest cached BioXcel Therapeutics Inc (BTAI) revenue for Dec 31, 2025 was $642.0K. Net income was -$69.9M. Statements: https://lician.com/financials/btai
What is BTAI's latest diluted EPS?
Latest cached BioXcel Therapeutics Inc (BTAI) diluted EPS for Dec 31, 2025 was -$5.73.
What period does the latest BTAI earnings print cover?
The latest cached BioXcel Therapeutics Inc (BTAI) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did BTAI revenue change from the prior cached period?
Cached BioXcel Therapeutics Inc (BTAI) revenue was down 71.7% from $2.3M (Dec 31, 2024) to $642.0K (Dec 31, 2025). Statements: https://lician.com/financials/btai
Where are BTAI earnings listed?
Cached earnings facts for BioXcel Therapeutics Inc (BTAI) are listed at https://lician.com/earnings/btai. Statements: https://lician.com/financials/btai
Not investment advice.